中华实验外科杂志
中華實驗外科雜誌
중화실험외과잡지
CHINESE JOURNAL OF EXPERIMENTAL SURGERY
2014年
11期
2444-2446
,共3页
于音%邵佳甲%田宇%程志华
于音%邵佳甲%田宇%程誌華
우음%소가갑%전우%정지화
内皮抑素%骨髓间充质干细胞%胶质瘤
內皮抑素%骨髓間充質榦細胞%膠質瘤
내피억소%골수간충질간세포%효질류
Endostatin%Bone marrow mesenchymal stem cells%Glioma
目的 探讨联合应用内皮抑素(ES)基因和骨髓间充质干细胞(BMSCs)治疗胶质瘤的有效性.方法 建立大鼠胶质瘤脑内模型;将转染了ES基因真核表达质粒的BMSCs注入模型鼠脑内,设立对照组,通过4组大鼠生存期、第6、12、18和24天肿瘤体积、病理切片、电镜检查、肿瘤坏死率及血管计数,比较各组治疗的差异.结果 大鼠生存期A组明显高于其他各组(P<0.01);肿瘤体积在第12天后,A组[(107.12±14.32) mm3]明显小于其他各组(P<0.05);A组肿瘤细胞凋亡较其他组明显;肿瘤坏死率A组(33.7%)明显高于其他各组(P<0.01);血管计数A组(5.73±0.02)明显少于其他各组(P<0.01).结论 应用内皮抑素基因联合BMSCs可有效治疗胶质瘤.
目的 探討聯閤應用內皮抑素(ES)基因和骨髓間充質榦細胞(BMSCs)治療膠質瘤的有效性.方法 建立大鼠膠質瘤腦內模型;將轉染瞭ES基因真覈錶達質粒的BMSCs註入模型鼠腦內,設立對照組,通過4組大鼠生存期、第6、12、18和24天腫瘤體積、病理切片、電鏡檢查、腫瘤壞死率及血管計數,比較各組治療的差異.結果 大鼠生存期A組明顯高于其他各組(P<0.01);腫瘤體積在第12天後,A組[(107.12±14.32) mm3]明顯小于其他各組(P<0.05);A組腫瘤細胞凋亡較其他組明顯;腫瘤壞死率A組(33.7%)明顯高于其他各組(P<0.01);血管計數A組(5.73±0.02)明顯少于其他各組(P<0.01).結論 應用內皮抑素基因聯閤BMSCs可有效治療膠質瘤.
목적 탐토연합응용내피억소(ES)기인화골수간충질간세포(BMSCs)치료효질류적유효성.방법 건립대서효질류뇌내모형;장전염료ES기인진핵표체질립적BMSCs주입모형서뇌내,설립대조조,통과4조대서생존기、제6、12、18화24천종류체적、병리절편、전경검사、종류배사솔급혈관계수,비교각조치료적차이.결과 대서생존기A조명현고우기타각조(P<0.01);종류체적재제12천후,A조[(107.12±14.32) mm3]명현소우기타각조(P<0.05);A조종류세포조망교기타조명현;종류배사솔A조(33.7%)명현고우기타각조(P<0.01);혈관계수A조(5.73±0.02)명현소우기타각조(P<0.01).결론 응용내피억소기인연합BMSCs가유효치료효질류.
Objective To discuss the effectiveness of endostatin gene combined with bone marrow mesenchymal stem cells (BMSCs) in treating brain glioma.Methods The rat glioma model in the brain was established.Four groups were set up randomly.The difference in curative effect among groups was compared by life span,tumor volume at 6th,12th,18th and 24th day,HE staining,transmission electron microscope and necrosis ratio.Results In group A,life span was extended obviously as compare with other groups (P <0.01).Tumor volume in group A [(107.12 ± 14.32) mm3] was diminished obviously as compared with group B [(395.47 ± 66.48) mm3] and group C [(382.74 ± 48.58) mm3,P < 0.05] at 12th day,which was diminished significantly as compared with group D [(539.45 ± 39.45) mm3,P < 0.01].Apoptosis was increased obviously in group A.Necrosis ratio and vessel counts in group A (33.7%,and 5.73 ±0.02) were obviously greater than other groups (P <0.01).Conclusion Endostatin gene combined with bone marrow BMSCs can treat glioma effectly.